Inovio stock surges 213.7% after FDA approval and analyst upgrade
AI Summary- Jefferies upgraded Inovio Pharmaceuticals to Buy after FDA approval of INO-3107 (Voceryq).
- Inovio closed at $1.89 from $0.6024, gaining 213.7% on heavy volume.
- Amdocs and NerdWallet each fell about 30% after downgrades followed negative company updates.